Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women (ANRS CO17)

This study has been completed.
Sponsor:
Collaborators:
Virology study Heather A Cubie Catherine Moore Edinburg United Kingdom
Anatomopathology study Christine Bergeron Laboratoire Pasteur Cerba Cergy Pontoise France
Isabelle Cartier Paris
Immunology study Guislaine Carcelain Groupe Hospitalier Pitié Salpétrière Paris
Surgery study Hervé Foulot Cochin Paris
Information provided by (Responsible Party):
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) ( French National Agency for Research on AIDS and Viral Hepatitis )
ClinicalTrials.gov Identifier:
NCT01311752
First received: July 16, 2010
Last updated: December 26, 2012
Last verified: December 2012

July 16, 2010
December 26, 2012
November 2007
November 2012   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01311752 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women
Study of Human Papillomavirus Related Genital Pathology Among HIV Positive

This study is a Multicentre cohort study with inclusion throughout the full duration of the study.

The primary objective is the study of human papillomavirus related genital pathology in HIV positive women.

The secondary objective are:

  1. To study the characteristics of HPV infection and related disease in the context of long term HAART and HIV infection ;
  2. To study the characteristics of atypical cells of uncertain significance detected in Pap smears, whose prevalence has dramatically increased in the last years;
  3. To describe cervical cancers observed in the cohort
  4. To study the evolution of recurrent high-grade lesions after surgery
  5. To describe the evolution of vaginal lesions developed after hysterectomy for high-grade lesions ;
  6. To describe the specific aspects of surgery for the treatment of cervical lesions according to the specific localization in the endocervix in HIV-positive women ;
  7. To study the in situ T cell HPV specific response in cervical lesions and the relationship between virological and clinical parameters, host immune status and natural history of lesions ;
  8. To initiate a prospective study on anal HPV infection and related disease among women infected with HIV.
  9. To initiate a study on therapeutic and/or prophylactic HPV vaccines in the context of immunosuppression and a high rate of HPV infection ;

Data were be collected into evaluate:

  • Analysis of prognostic factors (CD4, antiviral therapy) of cervical lesions, using Cox models.
  • Estimation of rates of Incidence of high grade lesions, of recurrence after surgical treatments using Kaplan Meier tests.
  • Logistic regression analysis for the study of factors associated with complete excision after surgical treatment.
  • SIR (standardised incidence rate) evaluation for cervical cancer

Study procedures are Annual follow-up in case of normal Pap smear, biannual follow-up in case of cervical lesions. Surgical management of High grade lesions.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

--

HIV Infections
Procedure: surgical management of high grade lesions

Clinical, pathological and biological, data at diagnosis and during follow-up will be collected.

Surgical sample will be collected to study human papillomavirus related genital pathology.

Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
676
December 2012
November 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • women > 18 years old
  • attending outpatient gynecology consultation
  • HIV positive
  • with written informed consent
  • on social security

Exclusion Criteria:

  • unaffiliated to the social healthy security french system
Female
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01311752
2007-A00703-50
Yes
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) ( French National Agency for Research on AIDS and Viral Hepatitis )
French National Agency for Research on AIDS and Viral Hepatitis
  • Virology study Heather A Cubie Catherine Moore Edinburg United Kingdom
  • Anatomopathology study Christine Bergeron Laboratoire Pasteur Cerba Cergy Pontoise France
  • Isabelle Cartier Paris
  • Immunology study Guislaine Carcelain Groupe Hospitalier Pitié Salpétrière Paris
  • Surgery study Hervé Foulot Cochin Paris
Principal Investigator: Isabelle Heard, MD Unité biologie de la reproduction, GH Pitié Salpétrière
Principal Investigator: Manuella Bonmarchand Service Médecine Interne La Pitié Salpétrière
Principal Investigator: Roland Tubiana Service maladies infectieuses La Pitié Salpétrière
Principal Investigator: Ana Canestri Service maladies infectieuses La Pitié Salpétrière
Principal Investigator: Catherine Creen Hebert Service Gynécologie-obstétrique Louis Mourier
Principal Investigator: Laurent Mandelbrot Service Gynécologie Louis Mourier
Principal Investigator: Francoise Meier Service Gynécologie Louis Mourier
Principal Investigator: Elisabeth Foucher Service Gynécologie Louis Mourier
Principal Investigator: Marie Jeanne Ducassou Hopital de jour CISIH Marseille
Principal Investigator: Isabelle Poizot Martin Hôpital de jour CISIH Marseille
Principal Investigator: Bénédicte Lefèvre Service des maladies infectieuses St Antoine
Principal Investigator: Bruno Carbonne Service Gynécologie St Antoine
Principal Investigator: Dahlia Torchin Service Gynécologie St Antoine
Principal Investigator: Anne Isabelle Richet Service Gynécologie St Antoine
Principal Investigator: Jean Paul Viard centre de diagnostic et thérapeutique Hopital Hotel Dieu
Principal Investigator: Christine Rousset Jablonski Service Gynécologie Obstétrique Hopital Hotel Dieu
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP